EURONEXT-PAR$ABVX

Abivax SA · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Headline financials

Total Revenue

€2.5M

No prior period
EPS (adj)

-€1.94

Previous: -€1.81-7.3%
Net Income

-€95.8M

Previous: -€40.3M-137.7%
Operating Income

-€92.5M

Previous: -€38M-143.2%
Gross Profit

-€378K

Previous: -€32K-1081.3%
R&D Expense

€70.6M

Previous: €32.8M+114.8%

Revenue & EPS history

Abivax SA · Revenue · Quarterly

€2.5M

Q4 2023
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 3 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+0.7%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+16.9%

Avg return

30 days after

67%

2 / 3 earnings

Positive

+1.5%

Q2 2025

Best reaction

-0.2%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025+1.5%-6.7%+0.7%
Q1 2025-0.2%+11.6%+30.1%
Q4 2023+0.9%+0.4%+20.1%
Q2 2023
Q4 2022
Q2 2022
Q4 2021
Q2 2021
Q4 2020
Q2 2020
Q4 2019
Q2 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro